Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ReNIM Study - Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing Nasal Interleukin-5 (IL-5) Measurements in Children With Allergic Rhinitis

NCT03349619 is registered in ClinicalTrials.gov with Istituto per la Ricerca e l'Innovazione Biomedica as lead sponsor.

NCT NCT03349619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03349619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ReNIM Study - Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing Nasal Interleukin-5 (IL-5) Measurements in Children With Allergic Rhinitis
Lead sponsor
Istituto per la Ricerca e l'Innovazione Biomedica
Phase
Phase 4
Overall status
Completed
Start date
March 5, 2018
Completion date
July 31, 2018
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis